AMPH
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Amphista Therapeutics doses the first patient in the Phase 1 AMX-883 clinical trial for acute myeloid leukemiaOct 12, 2026
- Amphastar Pharmaceuticals strengthens proprietary pipeline through exclusive licensing agreement with Nanjing Anji BiotechnologyAug 13, 2025
- Amphastar announces FDA approval for iron sucrose injection, USPAug 11, 2025